Brownstein Hyatt Farber Schreck is pleased to announce that Karla Arias has joined the firm’s Washington, D.C. office as of counsel in the Intellectual Property Department. She brings expertise in patent and trade secret litigation, as well as patent prosecution for clients in the chemical and pharmaceutical industries.
“Bringing Karla on board is a key step in our ongoing commitment to deepening our bench in high-stakes intellectual property matters,” said Airina Rodrigues, cochair of the firm’s IP Department. “Her unique combination of scientific rigor and legal insight will be an incredible asset to our clients, particularly those in the chemical and pharmaceutical sectors.”
Arias joins the firm from Crowell & Moring LLP, where she served as counsel in the Washington, D.C. office. Her extensive scientific background and legal acumen make her a valuable addition to the Brownstein team. Prior to her legal career, Arias was a postdoctoral fellow at Carnegie Mellon University, where she researched the degradation of endocrine-disrupting contaminants in water and the formation and reactivity of iron complexes.
She earned her doctorate in organic chemistry from the University of Zurich, focusing on the synthesis of supramolecular architectures and the study of fluorescent and phosphorescent properties of supramolecular building blocks. She also earned her J.D. from George Mason University and her bachelor’s degree from the University of California, San Diego.
TAGS:
CONTRIBUTORS:
Recent Insights
Read MoreAI is Reshaping the Landscape of International Trade Compliance
Presentation | February 23, 2026Policy Deep Dive – The Federal Tax Landscape: Guidance and Implications for Public Power
Client Alert | February 20, 2026Supreme Court Restricts Presidential Tariff Authority Under IEEPA
Presentation | February 19, 2026The Sports Gambling Scandals
Client Alert | February 17, 2026SLAPP Fight in Colorado: Plaintiffs Face Dueling Evidentiary Standards
Client Alert | February 17, 2026President Trump’s “America First Arms Transfer Strategy”
You have chosen to send an email to Brownstein Hyatt Farber Schreck or one of its lawyers. The sending and receipt of this email and the information in it does not in itself create and attorney-client relationship between us.
If you are not already a client, you should not provide us with information that you wish to have treated as privileged or confidential without first speaking to one of our lawyers.
If you provide information before we confirm that you are a client and that we are willing and able to represent you, we may not be required to treat that information as privileged, confidential, or protected information, and we may be able to represent a party adverse to you and even to use the information you submit to us against you.
I have read this and want to send an email.